1-6 of 6
Sharon Gardner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial

Clinical Trials & Observations
Michael A. Pulsipher, Bryan Langholz, Donna A. Wall, Kirk R. Schultz, Nancy Bunin, William L. Carroll, Elizabeth Raetz, Sharon Gardner, Julie M. Gastier-Foster, Denise Howrie, Rakesh K. Goyal, James G. Douglas, Michael Borowitz, Yvonne Barnes, David T. Teachey, Candace Taylor, Stephan A. Grupp
Journal: Blood
Blood (2014) 123 (13): 2017–2025.
https://doi.org/10.1182/blood-2013-10-534297
Published: 2014
Journal Articles

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

Michael A. Pulsipher, MD, Bryan Langholz, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, Julie M. Gastier-Foster, PhD, Michael J. Borowitz, MD, PhD, Rakesh Goyal, MD, MRCP, Sharon Gardner, MD, William L. Carroll, MD, Elizabeth Raetz, MD, Stephan A. Grupp, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 470.
https://doi.org/10.1182/blood.V120.21.470.470
Published: 2012
Journal Articles

A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431

Michael A. Pulsipher, MD, Bryan Langholz, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Sharon Gardner, MD, Julie M. Gastier-Foster, PhD, Denise Howrie, PharmD, Rakesh Goyal, MD, MRCP, Douglas James, MD, MRCP, Michael J. Borowitz, MD, PhD, Yvonne Jean Barnes, RN MSN CPNP, Shivanand R. Patil, PhD, David T Teachey, MD, Candace Taylor, CCRP, Stephan A Grupp, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 837.
https://doi.org/10.1182/blood.V118.21.837.837
Published: 2011
Journal Articles

Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Shirley Hogan, PharmD, Joy Mitchell, CRA, Vickie Massey, MD, Louis S. Constine, MD, Lu Chen, PhD, Cindy L. Schwartz, MD
Journal: Blood
Blood (2007) 110 (11): 1896.
https://doi.org/10.1182/blood.V110.11.1896.1896
Published: 2007
Journal Articles

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen Chen, MD, PhD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Robert Guillerman, MD, Shirley Hogan, PharmD, Joy Mitchell, Alan Gamis, MD, Vicki Massey, MD, Louis S. Constine, MD, Doojduen Villaluna, MS, Richard Sposto, MD, Cindy Schwartz, MD
Journal: Blood
Blood (2005) 106 (11): 2087.
https://doi.org/10.1182/blood.V106.11.2087.2087
Published: 2005
Journal Articles

AHOD00P1, a Pilot Study of Re-Induction Chemotherapy with Ifosfamide, and Vinorelbine (IV) in Children with Refractory/Relapsed Hodgkin Disease.

Tanya Trippett, M.D., Pedro De Alarcon, M.D., Wendy London, Ph.D., Richard Sposto, Ph.D., Allen Chen, M.D., Sharon Gardner, M.D., Cindy Schwartz, M.D.
Journal: Blood
Blood (2004) 104 (11): 2496.
https://doi.org/10.1182/blood.V104.11.2496.2496
Published: 2004